Allogene Therapeutics, Inc. (ALLO)
NASDAQ·Healthcare·Biotechnology
$1.68
-2.05%
Mkt Cap $583.31M
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (12 analysts)
$6.43
Range $3.85 – $9.00
Implied Upside
+283.9%
Consensus $6.43 vs current $1.68
NASDAQ·Healthcare·Biotechnology
$1.68
-2.05%
Mkt Cap $583.31M
Buy
4
Hold
1
Sell
0
Price Target (12 analysts)
$6.43
Range $3.85 – $9.00
+283.9%
Consensus $6.43 vs current $1.68